本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ionis Pharmaceuticals, Inc

51.44
-2.7700-5.11%
盤後51.850.4111+0.80%19:30 EDT
成交量:597.48萬
成交額:3.12億
市值:85.49億
市盈率:-14.78
高:55.50
開:54.88
低:51.31
收:54.21
52周最高:86.74
52周最低:50.01
股本:1.66億
流通股本:1.62億
量比:1.48
換手率:3.69%
股息:- -
股息率:- -
每股收益(TTM):-3.4800
每股收益(LYR):-2.3812
淨資產收益率:-105.50%
總資產收益率:-12.42%
市淨率:19.44
市盈率(LYR):-21.60

資料載入中...

2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/29

重要事件披露

Form 8-K - Current report
2026/04/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/21

重要事件披露

Form 8-K - Current report
2026/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/09

重要事件披露

Form 8-K - Current report